Roger McLendon

15PUBLICATIONS
98CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Data quality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 16, 2026
EGFR-targeted antibody-toxin conjugate in recurrent glioma: a phase 1 trial.

|Apr 27, 2026
Anti-VEGF vascular remodeling drives germinal center B cell-rich tertiary lymphoid structures during antibody-toxin and anti-CD40 combination therapy in glioblastoma.

|May 02, 2025
A Spatial Multi-Omic Framework Identifies Gliomas Permissive to TIL Expansion.

Mustafa Khasraw, Kelly Hotchkiss, Kenan Zhang

|Sep 28, 2023
Repurposing Clemastine to Target Glioblastoma Cell Stemness.

Michael A Sun, Rui Yang, Heng Liu

|Feb 08, 2023
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models.

Scott Parker, Charlotte McDowall, Luis Sanchez-Perez

|Apr 23, 2022
Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.

J Bryan Iorgulescu, Chuxuan Sun, Corey Neff

Pageof 3

Frequent Collaborators

3 joint publications

Vidyalakshmi Chandramohan

3 joint publications

Mustafa Khasraw

3 joint publications

Annick Desjardins

3 joint publications

Smita K Nair